Track topics on Twitter Track topics that are important to you
An international research team says it has discovered a new kind of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment. The group's study ("Tissue-Resident Memory Features Are Linked to the Magnitude of Cytotoxic T Cell Responses in Human Lung Cancer") appears in Nature Immunology . Investigators at the University of Southampton and the La Jolla Institute for Allergy & Immunology found that lung cancer patients with large amounts of a particular type of immune T cell, called tissue-resident memory T cells, in their tumor were 34% less likely to die. The team also found that it was not just the numbers of cells that increased survival, but also the cells’ behavior played a key role. The cells clustered together and took up residency in a particular tissue, in this case the cancer tissue, to protect the patient. These new ...NEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...